NeurogesX Round Brings In $35M To Fund Pivotal Trials, NDA Filing Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Aton Pharma Draws Attention Of Merck; Acquisition Planned Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Early Stage Drug Chances Better As Some Pharmas' Interest Shifts Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Discovery Partners, Pfizer Extend Collaboration By Two More Years Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Morphotek Raises $26M In Series C For Lead Product Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Neurobiologists At University Of Toronto Contest Doctrine That Copper Harms Alzheimer's Brain Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Progenics & Cytogen Report New Findings Covering Prostate Cancer Antibody and Vaccine Treatments Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Isis, Genta Antisense Results Top Off Lively ASCO Meeting Nov. 1, 2011 By Peter O'Donnell No Comments CHICAGO - A lively, data-chocked meeting of the American Society of Clinical Oncology here left analysts and attendees to sort the findings offered and determine their value in the weeks ahead.(BioWorld Today)Read More
Transgenic Plants Deliver Rabies Vaccines, Antibodies, As Infected Hamsters Confirmed Successfully Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
Novel Gene Emerges After Usual DNA's Work As Tumor Suppressor Via Epigenetics, Hypermethylation Nov. 1, 2011 By Peter O'Donnell No Comments No AbstractRead More
